# INHIBRX BIOSCIENCES, INC. (INBX) FY2026 Q2 P&L / Income Statement

- Company: INHIBRX BIOSCIENCES, INC. (INBX)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-13, accession number 0002007919-26-000042
- Page: https://plicit.ai/financials/inbx/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/inbx-fy2026-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 0 US dollars
- **Total operating expenses**: 32,149,000 US dollars
- **Loss from operations**: negative 32,149,000 US dollars
- **Total other expense**: negative 4,498,000 US dollars
- **Loss before income tax expense**: negative 36,647,000 US dollars
- **Provision for income taxes**: 3,000 US dollars
- **Net loss**: negative 36,650,000 US dollars
- **License fee revenue**: 0 US dollars
- **License fee revenue**: 0 US dollars
- **Total operating expenses**: 32,149,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.